Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
18-Sep-2020
Change of Director's Interest Notice - Dr. Robert Peach
18-Sep-2020
Change of Director's Interest Notice - Dr. C. Burns
18-Sep-2020
Section 708A Cleansing Notice - Allotment of Shares
18-Sep-2020
Appendix 2A - Application for Quotation of Shares
18-Sep-2020
Results of Annual General Meeting
18-Sep-2020
CEO Presentation to AGM
8-Sep-2020
Amplia Receives Ethics Clearance to Conduct Phase 1 Trial
2-Sep-2020
Appendix 3G - Notification of Issue of Securities - Options
31-Aug-2020
Amplia Appoints Dr Mark Devlin as Chief Scientific Officer
17-Aug-2020
Notice of Annual General Meeting & Proxy - YE 31 March 2020
Previous
1
2
3
4
5
6
7
Next